» Articles » PMID: 9625229

Psychiatric Comorbidity in Patients with Burning Mouth Syndrome

Overview
Journal Psychosom Med
Specialty Psychiatry
Date 1998 Jun 13
PMID 9625229
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The goal of this study was to evaluate the prevalence and type of psychiatric disorders coexisting with burning mouth syndrome (BMS), to compare the clinical features of patients with BMS alone with patients with multiple diagnoses, and to investigate the number and severity of life events that occur before the onset of BMS.

Method: There were 102 patients with BMS, with no possible local or systemic causes, who were evaluated according to the diagnostic criteria of DSM-IV. All axis I diagnoses for which the patients met criteria at intake or lifetime were determined. Life events were evaluated for a period of 6 months before the onset of BMS. A statistical comparison between patients and a matched control group was performed first; moreover, patients with BMS alone were compared with patients with comorbid BMS.

Results: Although 29 (28.4%) BMS patients were not given any other lifetime psychiatric diagnosis, high rates of comorbid psychiatric diagnoses were found. The most prevalent concurrent diagnoses were depressive disorders and generalized anxiety disorder. No significant differences emerged in clinical features between patients with and without other current psychiatric disorders. The severity of life events, rather than in their number, was significantly associated with BMS.

Conclusions: BMS has high psychiatric comorbidity but can occur in the absence of psychiatric diagnoses.

Citing Articles

Salivary hormones in depression: the future in diagnosis and treatment.

Harsanyi S, Kupcova I, Csobonyeiova M, Klein M Ann Gen Psychiatry. 2025; 24(1):9.

PMID: 39962602 PMC: 11834473. DOI: 10.1186/s12991-025-00548-y.


Clinical Features and Variations of Pain Expressions in 834 Burning Mouth Syndrome Patients With or Without Psychiatric Comorbidities.

Takao C, Watanabe M, Nayanar G, Tu T, Umezaki Y, Takenoshita M Cureus. 2024; 15(12):e51139.

PMID: 38283479 PMC: 10811297. DOI: 10.7759/cureus.51139.


Topical gabapentin solution for the management of burning mouth syndrome: A retrospective study.

Gramacy A, Villa A PLoS One. 2023; 18(12):e0295559.

PMID: 38096135 PMC: 10721041. DOI: 10.1371/journal.pone.0295559.


The influence of intolerance of uncertainty on the correlation between the severity of symptoms and satisfaction with oral state in patients with burning mouth syndrome.

Utsunomiya M, Matsuoka H, Takenoshita M, Toyofuku A, Miura H, Abiko Y Clin Oral Investig. 2022; 26(11):6563-6568.

PMID: 35790598 DOI: 10.1007/s00784-022-04606-7.


Neuropathic and Psychogenic Components of Burning Mouth Syndrome: A Systematic Review.

Orliaguet M, Misery L Biomolecules. 2021; 11(8).

PMID: 34439903 PMC: 8393188. DOI: 10.3390/biom11081237.